SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Dose-response relationship between genetically proxied average blood glucose levels and incident coronary heart disease in individuals without diabetes mellitus.

Burgess, S; Malik, R; Liu, B; Mason, AM; Georgakis, MK; Dichgans, M; Gill, D (2021) Dose-response relationship between genetically proxied average blood glucose levels and incident coronary heart disease in individuals without diabetes mellitus. Diabetologia, 64 (4). pp. 845-849. ISSN 1432-0428 https://doi.org/10.1007/s00125-020-05377-0
SGUL Authors: Gill, Dipender Preet Singh

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (802kB) | Preview

Abstract

AIMS/HYPOTHESIS: Our aim was to investigate the relationship between average blood glucose levels and incident CHD in individuals without diabetes mellitus. METHODS: To investigate average blood glucose levels, we studied HbA1c as predicted by 40 variants previously shown to be associated with both type 2 diabetes and HbA1c. Linear and non-linear Mendelian randomisation analyses were performed to investigate associations with incident CHD risk in 324,830 European ancestry individuals from the UK Biobank without diabetes mellitus. RESULTS: Every one mmol/mol increase in genetically proxied HbA1c was associated with an 11% higher CHD risk (HR 1.11, 95% CI 1.05, 1.18). The dose-response curve increased at all levels of HbA1c, and there was no evidence favouring a non-linear relationship over a linear one. CONCLUSIONS/INTERPRETATIONS: In individuals without diabetes mellitus, lowering average blood glucose levels may reduce CHD risk in a dose-dependent way.

Item Type: Article
Additional Information: © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Keywords: Average blood glucose levels, CHD, Mendelian randomisation, Endocrinology & Metabolism, 1103 Clinical Sciences, 1114 Paediatrics and Reproductive Medicine, 1117 Public Health and Health Services
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Diabetologia
ISSN: 1432-0428
Language: eng
Dates:
DateEvent
April 2021Published
26 January 2021Published Online
19 November 2020Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
RE/18/4/34215British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
204623/Z/16/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
PubMed ID: 33495845
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112890
Publisher's version: https://doi.org/10.1007/s00125-020-05377-0

Actions (login required)

Edit Item Edit Item